Title | Intervention |
NCT ID![]() |
Sponsor | Status |
---|---|---|---|---|
Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With... | Recombinant Human Papillomavirus Nonavalent Vaccine | NCT04265950 | Fred Hutchinson Cancer Center | Recruiting |
A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of... | Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy, Quality-of-Life Assessment, Questionnaire Administration | NCT04251052 | NRG Oncology | Recruiting |
Marker Driven Selection of Patients for Prostate Biopsy and Management | NCT04240327 | University of Miami | Recruiting | |
Comparing Two Methods to Follow Patients With Pancreatic Cysts | Computed Tomography, Endoscopic Ultrasound, Magnetic Resonance Imaging, Quality-of-Life Assessment, Questionnaire Administration | NCT04239573 | ECOG-ACRIN Cancer Research Group | Recruiting |
Implementation and Effectiveness Trial of HN-STAR | HN-STAR Intervention | NCT04208490 | Wake Forest University Health Sciences | Recruiting |
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) | Placebo, Sulindac 400 MG | NCT04207944 | Duke University | Recruiting |
Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal... | Best Practice, Dietary Intervention, Message, Quality-of-Life Assessment, Questionnaire Administration | NCT04205955 | Southwest Oncology Group | Active, not recruiting |
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III... | Nilotinib, Nilotinib Hydrochloride Monohydrate, Paclitaxel, Placebo, Questionnaire Administration | NCT04205903 | Ohio State University Comprehensive Cancer Center | Recruiting |
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation | Enhanced care, Potlako intervention | NCT04141449 | Brigham and Women's Hospital | Recruiting |
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III... | Duloxetine, Duloxetine Hydrochloride, Oxaliplatin, Placebo, Quality-of-Life Assessment, Questionnaire Administration | NCT04137107 | Alliance for Clinical Trials in Oncology | Recruiting |
Why I Joined a Clinical Trial
I hope my participation has enabled the NCI to further their important research.